Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer

Documenti analoghi

• N‐glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas
  di: Hirotake Kodama, et al.
  Pubblicazione: (2021-02-01)
• Serum N-Glycan Profiling Predicts Prognosis in Patients Undergoing Hemodialysis
  di: Shingo Hatakeyama, et al.
  Pubblicazione: (2013-01-01)
• Utility of plasma cell‐free DNA in metastatic castration‐resistant prostate cancer
  di: Itsuto Hamano, et al.
  Pubblicazione: (2020-07-01)
• Clinical implications of serum N‐glycan profiling as a diagnostic and prognostic biomarker in germ‐cell tumors
  di: Takuma Narita, et al.
  Pubblicazione: (2017-04-01)
• Hyaluronic acid degrading enzyme: TMEM2 increase in patients with interstitial cystitis and bladder pain syndrome
  di: H. Yamamoto, et al.
  Pubblicazione: (2020-07-01)